Illumina, Inc. - Common Stock (ILMN)
279.47
+8.43 (3.11%)
NASDAQ · Last Trade: Oct 27th, 7:05 PM EDT
News & Press Releases
Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE?fool.com
BBH offers lower costs and concentrated large-cap exposure, while PBE delivers higher dividend income and slightly better five-year returns through a multifactor strategy.
Via The Motley Fool · October 27, 2026
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT?fool.com
FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.
Via The Motley Fool · October 26, 2026
Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy?fool.com
RSPH offers broader healthcare exposure with lower volatility and higher dividend yield, while IBB provides concentrated biotech focus with stronger recent returns.
Via The Motley Fool · October 26, 2026
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth?fool.com
These two healthcare ETFs offer investors exposure to some of medicine's biggest names, but their different approaches to investing could lead to very different results.
Via The Motley Fool · October 25, 2026
S&P 500 Top Movers: Oct. 21, 2026 US Sessionchartmill.com
Via Chartmill · October 21, 2026
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Loserschartmill.com
Via Chartmill · October 21, 2026
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winningmarketbeat.com
AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound.
Via MarketBeat · October 19, 2026
3 Profitable Stocks We Steer Clear Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via StockStory · October 12, 2026
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lensfool.com
PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.
Via The Motley Fool · October 11, 2026
Better Biotechnology ETF: First Trust FBT vs. VanEck BBHfool.com
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings.
Via The Motley Fool · October 10, 2026
Which S&P500 stocks are gapping on Thursday?chartmill.com
Via Chartmill · October 8, 2026
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Via Chartmill · October 6, 2026
Which S&P500 stocks are moving on Tuesday?chartmill.com
Via Chartmill · October 6, 2026
Tuesday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Via Chartmill · October 6, 2026
Stocks making big moves yesterday: Harley-Davidson, Illumina, TechnipFMC, Upstart, and DraftKings
Check out the companies making headlines yesterday: Harley-Davidson (NYSE:HOG): American motorcycle manufacturing company Harley-Davidson (NYSE:HOG) rose by ...
Via StockStory · October 6, 2026
Why PacBio (PACB) Stock Is Trading Up Today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 9.9% in the afternoon session after EpiSign Inc. and Geneyx ...
Via StockStory · October 5, 2026
Illumina (ILMN) Shares Skyrocket, What You Need To Know
What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 7.7% in the afternoon session after Wall Street analysts lifted their price targets d...
Via StockStory · October 5, 2026
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Via Chartmill · October 5, 2026
Which S&P500 stocks are moving on Monday?chartmill.com
Via Chartmill · October 5, 2026
3 Reasons to Buy Grail (GRAL) Hand Over Fist in Octoberfool.com
The cancer blood test maker could have a bright future.
Via The Motley Fool · September 30, 2026
Why Is PacBio (PACB) Stock Soaring Today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 29.7% in the afternoon session after EpiSign announced the l...
Via StockStory · September 30, 2026
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?fool.com
Illumina's AI strategy is reshaping the investment case. See how sequencing, biological data, and drug-discovery partnerships could change what drives the company next.
Via The Motley Fool · September 29, 2026
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
What a fantastic six months it’s been for Illumina. Shares of the company have skyrocketed 126%, hitting $273.47. This was partly due to its solid quarterly ...
Via StockStory · September 29, 2026
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentummarketbeat.com
Waters (NYSE:WAT) President and Chief Executive Officer Udit Batra said the company’s second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses.
Speaking at a JPMo
Via MarketBeat · September 26, 2026
AI-Assisted Clinical Research Could Accelerate Personalized Medicinetalkmarkets.com
The global personalized medicine market was valued at USD 567.1 billion in 2024. It is projected to reach USD 656.5 billion in 2026 and USD 1,196.2 billion
Via Talk Markets · September 23, 2026